Analysis Of Marcia Angell's The Truth About The Drug Companies

1052 Words3 Pages
bulb-icon

Recommended: principles of effective management

There seems to be no law protecting patients from the price increases that these big pharmaceutical companies are making. Marcia Angell, is an American physician, author, and the first woman to serve as editor-in-chief of the New England Journal of Medicine. In chapter 10 of her book, The Truth About the Drug Companies, she talks about stretching out the idea on monopoly. Patents makes it illegal for a specific set amount of time for competitors to sell the same/similar drugs. Once the patent is over, when the company loses its rights to a drug, the Food and Drug Administration (FDA) arranges for the generic version of the drugs made by a different company to go out on the market. When there is only one generic brand on the market, the cost may not be as cheap because the generic brand and the brand name shadow prices. This keeps the generic version just beneath the price of the brand name. Although the generic is not that much cheaper than the brand name, in the course of one year, the brand name company will lose hundred of millions of dollars due to generic drugs. From an economic point of view, …show more content…

Doctor Tristram Engelhardt, an American philosopher, argues that the importance of these profits is to acquire resources and to productively make new discoveries. These profits will secure recourses for these companies and that with the extra money, these pharmaceutical companies can be more innovative. With these profits, more effort will be put in to decreasing morbidity and mortality risks. According to Engelhardt, if these companies decrease profits, the amount of resources and energies available to be innovative will also decrease, leading to more risks. However, Stan Frinkelstein and Peter Temin states that we can eliminate the link between drug prices and drug discovery by developing the Drug Development Corporation, that will solve this problem, as mention in the last

Show More
Related

  • Epipen Case Study

    834 Words  | 2 Pages

    This is definitely a problem for consumers because they can have ties with the pharmaceutical and they have the ability to evoke the best interests for their company when pricing drugs. According to the drug makers and the intermediaries, the higher cost are needed to pay of rebates and providing discounts for insurers and employers. Despite providing incentives to those with insurance, this alienates those who have little to no insurance, they are left to burden the higher drug prices. In the U.S., there isn’t a checks and balances system when it comes to drug pricing like in the U.K. therefore some critics do not blame Mylan for raising the price for these drugs. Making and testing for innovative medicines requires years of research, which means money. Therefore, I do understand that drug makers, the pharmaceutical company and its investors want to get paid for the amount of time and money that they put into their new drug. However, I believe that they need to find that particular medium that helps the people especially those who are less fortunate and in need for this life-saving medication while being able to make a

    Read More

  • Ethical Issues In The Pharmaceutical Industry

    802 Words  | 2 Pages

    For years, the price of drugs have been held in congress because the cost of pharmaceutical drugs is the most controversial aspect of this industry. Stuart Schweitzer, a professor of health policy and management at the University of California Los Angeles, author of Pharmaceutical Economics and Policy, comments on this topic. According to Schweitzer, consumers are more sensitive to drug prices more than the price other health services. Schweitzer states, “Consumers are more likely to complain about a $50 bottle of tablets than a $500 radiology procedure, or a $5000 hospital stay”. This may be due the fact that these procedure and hospital stays are less frequent than taking prescription medication that is needed continuous. Most patients are seeing multiple doctors and nurses, that is accounting for the cost. Whereas at a pharmacy, they only see the pharmacist for a consultation and then the patient goes home to take their medication. Consumers may expect this to be cheaper because they are not receiving extensive care. To bring a new drug onto the market in the 1990s, it costed $359 million compared to $1.7 billion in 2003. Pricing of most products is usually based on marginal cost, which is the change in the total cost that comes from producing one extra item. However, this is not the case with the pharmaceutical industry because if prices were based on marginal cost, drugs would be a lot more

    Read More

  • Drug Patents

    1902 Words  | 4 Pages

    Why do consumers purchase specific drugs for various ailments, sicknesses or diseases they might have? Why do physicians prescribe certain drugs over competitive drugs that may be available to the public? Why is it that most of us can easily name specific drugs that fit the many ailments of today’s society? On the surface the answer might be as simple as good TV advertising or radio commercials or even internet adds. The truth of matter is the major pharmaceutical manufacturers own the patents on these drugs and this gives them all of the marketing budget and muscle they need to promote the drug and control the pricing. The incentives for larger pharmaceutical companies are very enticing and as a result, they don’t mind spending the time in clinical trials and patent courts to get their drugs approved. Some will even get patents on the process by which the drug is manufactured, ensuring that no competitor can steal the drug or the process. This protects their large financial investment and nearly guarantees a large return for their investors. Many consumer rights groups claim this is nothing more than legalizing monopolies for the biggest manufacturers.

    Read More

  • The War on Pharmaceutical Companies

    1185 Words  | 3 Pages

    It is said that name-brand prescription drugs in Canada cost approximately 40% less than they do in America. But it is illegal for the transport of drugs from Canada to America. Why? It is because Pharmaceuticals are simply greedy and prey on victims that are in need of their products to survive. It makes it hard for large households on a budget to purchase drugs to keep healthy. The way pharmaceutical companies look at their clients is like this: It is a life or death situation for them so the customers have to buy it in order to survive. According to the annual Fortune 500 survey, the pharmaceutical industry, expectedly, made it at the top of the list of the most profitable. The top seven pharmaceutical companies took in more profit-money than the top seven media companies, the top seven airline companies, the top seven oil companies, and the top seven car manufacture companies. (…cost so much, CNN) The profits of pharmaceutical companies are outrageous and extreme. There are many reasons to why these companies are greedily taking advantage of customers. The number one reason is because people who are need of these prescriptions have no other choice but to purchase them.

    Read More

  • Epipen Case Analysis

    661 Words  | 2 Pages

    The main controversy here is the question of whether or not Mylan was price gouging with the EpiPen. Unfortunately the answer to this question does not matter. It appears as tho the 500% raise in the price of the EpiPen over the past 7 years is ethically and morally wrong, but when it comes to the law they have done nothing wrong. Pharmaceutical companies are legally allowed to charge whatever they want for their products. The largest insurer in the United States of America, which is Medicare, actually rewards doctors for prescribing costly drugs. On top of being rewarded for issuing costly drugs, it is illegal for Medicare to negotiate prices on drugs. (Source) This most definitely does not help the price situation when it comes to pharmaceuticals.

    Read More

  • Over Prescription Drugs Case Study

    442 Words  | 1 Pages

    Many patients discontinue with their drug treatments due to them being highly priced.1 Regulated drug price control may benefit the public but not so much for the economy. The revenues and profits that companies make are used mainly to advertise new drug treatments and fund clinical research. Pharmaceutical companies spend only 1.3% of their revenues on basic research.1 This make no sense that only a small portion is used for research while the rest is spent on marketing. Price controlling may reduce marketing and advertising on new drugs, which may in return produce low revenues and profits for the company. Then we ask ourselves, what matters most the people or

    Read More

  • Merck's Case Ethical

    1740 Words  | 4 Pages

    ...f ivermectin in the first place. Furthermore, we wouldn’t want to risk Merck going out of business, as it seems they had the capability to produce many useful medications. They’d already proved to make six useful, safe, and powerful drugs—the medical world wouldn’t want to lose such able creators. The best choice, therefore, would have Merck contributing to the research, but include other pharmaceutical companies and private donors to help with the financial and personnel costs. This funding would allow Merck and the other companies to sell at low costs, or even give, the medication to those who desperately need it. In order to implement such this type of plan, Merck would have to take the lead. They would have to actively seek out organizations, companies and private donors and explain the wonderful consequences for huge populations with the success of ivermectin.

    Read More

  • Argumentative Essay On Drug Advertising

    2059 Words  | 5 Pages

    Prices continue to increase with no end in sight. Although there are a number of reasons for this trend direct to consumer drug advertising is partially to blame. The American Medical Association has spoken out against drug advertising. Stating that the ads are driving up drug costs by convincing the consumer that the brand name drug is the one they need the most. Doctors feel pressured by patient into prescribing brand name drugs instead of their cheaper counterparts. Brand name drugs cost more than generic drugs. On average brand name drugs cost 80% more than their generic counterparts. Yet patients will often come in and request the band name drug. Insisting that the drug they saw on television is the one they need. Most doctors will give in to the patient’s requests. Patients are needlessly increasing their own medical costs because they incorrectly believe that the drug they saw on TV is safer and more effective. This is not the case. The United States Food and Drug Administration (FDA) require all generic drugs to prove they are identical to their brand name counterparts, even going as far as to have both generic and brand name drugs have the same active ingredients, strength, dosage form, and route of administration. Generic drugs are just as safe and effective as brand name drugs and cost considerably less. Yet patients continue to request overpriced brand name

    Read More

  • Universal Prescription Drug Prices: A Case Study

    667 Words  | 2 Pages

    Even though their price raised about 500% there is still no law to bring them to court since the pharmaceutical side of business is allowed to increase the price as much as they want. Most states however, have their own price gouging regulations under their own state law. Although some of these state specifically state as to which product is not allowed to price gouge, some states like Virginia on any necessary goods and services (Gilberson, 2012). Having about 35 states create regulations about price gouging prove this influx in price is a huge issue when it comes to the American public’s necessities in which all people should be able to

    Read More

  • A Prescription for Profit

    582 Words  | 2 Pages

    In 2007, the pharmaceutical industry spent approximately $4.8 billion dollars a year advertising prescription drugs directly to the public (ProCon.org 2005). A study by two York University researchers estimates the U.S. pharmaceutical industry spends nearly twice as much on promotion as it does on research and development (York University, 2008). Why do they spend so much money marketing to the consumer? The simple answer is profit. Like any other business pharmaceutical companies are out to sell a product and make money. The primary concern of the pharmaceutical industry is not the welfare of the consumer but convincing them to take their drug. In order to eliminate this conflict of interest the pharmaceutical industry should be banned from directly marketing their products to the consumer.

    Read More

  • The Pros And Cons Of Transnational Pharmaceutical Companies

    516 Words  | 2 Pages

    A compulsory licensing regime might not contribute so much to build national industries, but actually helps the agencies to negotiate drug prices with transnational pharmaceutical companies. Instead

    Read More

  • Generic Drug Savings

    554 Words  | 2 Pages

    Generic drug savings are widely recognized as a long-term solution to rising health costs. The 2014 Express Scripts Drug Trend Report shows that since 2008, the price of brand drugs has almost doubled but the price of generic drugs has been cut roughly in half.6 Purchasing generic versions instead of their brand-name equivalent drugs can provide substantial savings, not only for state and local governments and Medicaid programs, but also for health insurers, employers, employees, and direct pay patients.11 The need for prescriptions typically increases with age and the savings made possible by generic drug use among older adults and seniors are critical to sustaining affordable health care.6

    Read More

  • The Rise in the Price of Prescription Drugs

    1345 Words  | 3 Pages

    Why are the prices so high? Some critics of the drug companies argue that the larger firms are ripping off the American public, are dishonest and, in some cases, unsafe. On the other hand, there are health care workers such as doctors and their supporters who claim that research and testing for drugs costs money. This supposedly justifies their prices for their products. Also, as an argument to their side, they say that their practice is a benefit to the improvement to mankind. It is a life saving business, but are these prices justified? As one can see, this is a very important issue in medicine today. It affects everyone involved with medicine, which is much of the American public. It also affects the physicians and drug makers.

    Read More

  • Persuasive Essay On Prescription Drugs

    569 Words  | 2 Pages

    This is putting the customers in jeopardy. They don't have a choice when it comes to medication. Having such high prices also puts the patients at risk. If you don't have enough money to buy something, you obviously can't buy it, but prescriptions are essential to many people's lives and if you can't take them because of the prices it could be hazardous. The United States ended up spending 374 billion dollars on prescription drugs in 2014 and the price is only going to increase. I believe that the prices for medications should go down because sometimes you can't help it and you really don't want to be paying for medicine, but you don't have a choice. There are also people who don't have insurance because they cant afford it, and that also impacts the price of the prescription. Having no insurance depend on the drug you need, can make a huge difference.

    Read More

  • Disease Mongering: Exploiting Sickness by Big Pharmaceuticals

    1532 Words  | 4 Pages

    Of these wants and needs it, optimal health status is highly desired. The objective of the pharmaceutical industry is to create medications that help maintain and promote health for a variety of illnesses and disabilities. This business is very lucrative - as long there are people, there will be a demand for health goods and services. Though there is a demand and need for these goods, it does not mean there is equal access. The pharmaceutical industry is one of allocative inefficiency and distributional inequity; the pharmaceutical market holds traits closest to an oligopoly, and pharmaceutical goods tend to be unfairly distributed. The pharmaceutical market structure closely resembles an oligopoly because the top 10 largest companies control one-third of the

    Read More

More about Analysis Of Marcia Angell's The Truth About The Drug Companies

Open Document